Carisma Therapeutics, Inc. (CARM)

NASDAQ: CARM · IEX Real-Time Price · USD

1.680

-0.020 (-1.18%)

At close: Apr 24, 2024, 4:00 PM

1.720

+0.040 (2.38%)

After-hours: Apr 24, 2024, 7:37 PM EDT

Carisma Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Cash & Equivalents	77.61	24.19	162.64	55.39	48.14	50.44	14.69	25.35	36.17	54.15	Upgrade
Short-Term Investments	0	27.8	0	0	0	0	0	0	0	0	Upgrade
Cash & Cash Equivalents	77.61	52	162.64	55.39	48.14	50.44	14.69	25.35	36.17	54.15	Upgrade
Cash Growth	49.25%	-68.03%	193.63%	15.06%	-4.56%	243.38%	-42.06%	-29.91%	-33.20%	573.88%	Upgrade
Receivables	0	0	24.49	0	0	0	0	0	0	0	Upgrade
Other Current Assets	2.87	2.6	18.48	7.48	6.31	1.31	0.29	0.58	0.14	0.25	Upgrade
Total Current Assets	80.47	54.59	205.61	62.87	54.45	51.76	14.98	25.93	36.31	54.4	Upgrade
Property, Plant & Equipment	8.94	13.45	0.04	0.12	0.24	0.32	0.52	0.8	0.41	0.49	Upgrade
Long-Term Investments	0	0	0.02	0.02	0	0	0	0	0	0	Upgrade
Goodwill and Intangibles	0	0	27.76	59.46	59.46	59.46	59.46	77.36	0	0	Upgrade
Other Long-Term Assets	0.15	4.11	7.32	0.35	0.22	0.02	0.13	0.01	0.11	0.11	Upgrade
Total Long-Term Assets	9.08	17.56	35.14	59.96	59.92	59.81	60.12	78.17	0.51	0.6	Upgrade
Total Assets	89.55	72.15	240.75	122.82	114.37	111.56	75.1	104.1	36.83	55	Upgrade
Accounts Payable	3.93	1.73	2.85	3.1	1.9	1.37	0.91	1.78	1.25	2.46	Upgrade
Deferred Revenue	46.41	47.46	1.5	3	0	0	0	0.43	0.41	0.51	Upgrade
Current Debt	1.94	4.6	0	0	0	0	0	0	4.13	0.25	Upgrade
Other Current Liabilities	-36.37	-34.12	7.22	11.95	6.62	4.75	3.81	1.77	1.79	1.99	Upgrade
Total Current Liabilities	15.91	19.67	11.57	18.05	8.52	6.11	4.72	3.98	7.58	5.2	Upgrade
Long-Term Debt	1.19	35.57	0	0	0	0	0	0	9.76	9.75	Upgrade
Other Long-Term Liabilities	45.93	51.78	57.47	114	132.55	61.24	52.34	61.44	0.54	3.22	Upgrade
Total Long-Term Liabilities	47.11	87.35	57.47	114	132.55	61.24	52.34	61.44	10.3	12.97	Upgrade
Total Liabilities	63.02	107.02	69.04	132.05	141.07	67.35	57.06	65.42	17.88	18.17	Upgrade
Total Debt	3.12	40.16	0	0	0	0	0	0	13.9	10	Upgrade
Debt Growth	-92.22%	-	-	-	-	-	-	-	38.97%	121.34%	Upgrade
Retained Earnings	-245.1	-158.22	-316.26	-315.92	-293.52	-186.02	-152.33	-123.31	-125.2	-91.75	Upgrade
Comprehensive Income	0	-0.04	0	0	0	0	0	0	0	0	Upgrade
Shareholders' Equity	26.53	-157.07	171.71	-9.23	-26.7	44.21	18.03	38.68	18.94	36.83	Upgrade
Net Cash / Debt	74.48	11.83	162.64	55.39	48.14	50.44	14.69	25.35	22.28	44.15	Upgrade
Net Cash / Debt Growth	529.50%	-92.72%	193.63%	15.06%	-4.56%	243.38%	-42.06%	13.81%	-49.55%	1155.06%	Upgrade
Net Cash Per Share	2.22	5.56	17.84	9.37	10.59	16.33	11.25	23.33	23.46	60.30	Upgrade
Working Capital	64.56	34.92	194.04	44.82	45.93	45.64	10.26	21.95	28.73	49.2	Upgrade
Book Value Per Share	0.79	-73.81	18.84	-1.56	-5.87	14.31	13.82	36.69	19.95	50.30	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).